Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Case report

Rupture of a subungual glomus tumor of the finger

Authors: Hui Lu, Li Feng Chen, Qiang Chen

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Glomus tumor is a rare benign neoplasm, which most frequently occurs in the subungual regions of digits. Tumor rupture and infection occurred in one patient with a glomus tumor have never been reported.

Case presentation

We report a 59-year-old female presented to our hospital with a five-year history of progressively sharp pain and severe tenderness in the tip of her right middle finger. The treatment was surgical excision through a lateral incision accompanied with removal of the nail. After the surgery, the patient gained a functional recovery of her previously afflicted finger.

Conclusions

To the best of our knowledge, this is the first case of finger infection caused by a ruptured subungual glomus tumor. Patients and physicians should be aware of the properties of glomus tumor so that early diagnosis and treatment of subungual glomus tumor as well as avoidance of tumor rupture and infection can be achieved.
Literature
1.
2.
Polman LJ, De Kort GA. Glomus tumor of the finger. JBR-BTR : organe de la Societe royale belge de radiologie. 2001;84(2):73.
3.
Masson P. Le Glomus neuromyo-arteriel des régions tactiles et ses tumeurs. Lyon Chirurgical. 1924;20:257–80.
4.
Fujioka H, Kokubu T, Akisue T, Nagura I, Toyokawa N, Inui A, et al. Treatment of subungual glomus tumor. The Kobe journal of medical sciences. 2009;55(1):E1–4.PubMed
5.
6.
7.
8.
Schneider LH, Bachow TB. Magnetic resonance imaging of a glomus tumor. A case report. Orthop Rev. 1991;20(3):255–6.PubMed
9.
10.
Takata H, Ikuta Y, Ishida O, Kimori K. Treatment of subungual glomus tumour. Hand Surg. 2001;6(1):25–7.CrossRefPubMed
11.
Rohard I, Subotic U, Weber DM. Primary reconstruction of fingernail injuries in children with split-thickness nail bed grafts. Eur J Pediatr Surg. 2012;22(4):283–8.CrossRefPubMed
Metadata
Title
Rupture of a subungual glomus tumor of the finger
Authors
Hui Lu
Li Feng Chen
Qiang Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4377-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer

Research article

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

Research article

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma

Case report

A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report

Research article

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia

Case report

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits